What question did this study set out to answer?

This study aims to synthesize and evaluate novel quinazolin-4(3H)one derivatives for their efficacy against malaria.

June 12, 2026Open Access

Design, Synthesis, and Antimalarial Evaluation of Novel Quinazolin-4(3 H )-one Derivatives with Molecular Modeling Insights into Target Selectivity

Key Points

This study aims to synthesize and evaluate novel quinazolin-4(3H)one derivatives for their efficacy against malaria.
Synthesized 36 quinazolin-4(3H)one analogs and assessed their antiplasmodial activity against P. falciparum.
Characterized compounds for cytotoxicity and determined selectivity indexes.
Conducted molecular modeling to identify binding modes and target selectivity.
Compounds 3d, 3e, 4a, and 4e showed promising antiplasmodial activity (IC50 values 1.70-4.36 μM).
Cytotoxicity assessments revealed no harmful effects with CC50 values of 22.91-48.15 μM.
Molecular dynamics simulations indicated 4a's stability against PfNMT with a binding energy of ΔG binding = −130.873 kJ/mol.

Abstract

High Resolution Image Download MS PowerPoint Slide Malaria is a tropical disease caused by protozoa of the genus Plasmodium and is responsible for several deaths worldwide. Current therapies are limited by the high incidence of adverse effects and the rising prevalence of parasite drug resistance, underscoring the need for research into new chemical scaffolds that can overcome these limitations and for the identification of novel drug targets to advance antimalarial development. In this context, quinazolines show promising potential as new antimalarials. Therefore, in this study, a new series of quinazolin-4(3 H )-one analogs was synthesized and evaluated for antiplasmodial activity. As a result, 36 compounds were synthesized and characterized, of which 3d, 3e, 4a, and 4e showed promising activity in assays against P. falciparum -3D7HT-GFP (IC 50 = 4.36, 2.26, 1.70, and 4.10 μM) with no cytotoxicity (CC 50 = 44.56, 22.91, 26.42, and 48.15 μM) and acceptable selectivity indexes (10.22, 10.14, 15.55, and 11.75). The compounds were evaluated against Leishmania donovani and Trypanosoma congolense but did not inhibit these parasites, suggesting that this chemical scaffold is selective for plasmodial targets. Accordingly, molecular modeling proposed N -myristoyltransferase (NMT) as a potential target and identified the specific binding mode of compound 4a for P. falciparum NMT (PfNMT) relative to L. donovani NMT (LdNMT), T. congolense NMT (TcNMT), and Homo sapiens NMT (HsNMT). It was found that the presence of Leu 411, Leu 369, Ser 337, and Phe 336 in PfNMT, substituted by Met 412, Val 370, Val 338, and Tyr 337 in LdNMT, and Met 445, Tyr 370, Ile 371, and Tyr 370 in TcNMT, may be related to the predicted target selectivity and the greater affinity of 4a for PfNMT. Finally, molecular dynamics simulations suggest that 4a is most stable against PfNMT, and MM-PBSA calculations indicate a binding energy for this target (Δ G binding = −130.873 kJ/mol). These findings corroborate the promising potential of 4a and support its proposed selectivity against PfNMT, yielding a scaffold that can be explored in subsequent optimization studies.

Read Full Paperexternally

Mark Helpful

Bookmark

Relay

View Full Paper